Short Summary
The plaintiffs filed a civil suit against the defendants regarding the patent rights related to the manufacturing process of Phosphorous Pentachloride. The court framed several issues, including infringement, entitlement to injunction and damages, and the validity/revocation of Patent No. 172459.
Detailed Summary
In the world of chemical manufacturing, a patented process can be the crown jewel of a company's intellectual property portfolio. But what happens when that crown jewel is challenged, contested, or allegedly copied? The dispute between Rajnikant and the pharmaceutical defendants brings this exact tension to the forefront, raising fundamental questions about how process patents are protected, defended, and ultimately judged in the courtroom.
The plaintiffs, Rajnikant, held Patent No. 172459, which covered a specific manufacturing process for Phosphorous Pentachloride — a chemical compound widely used in pharmaceutical and industrial applications. Believing that their patented process had been infringed upon, the plaintiffs filed a civil suit against the defendants, who were operating in the pharmaceutical sector. The dispute centered not just on whether infringement had occurred, but on the very foundation of the patent itself. The court was called upon to examine multiple dimensions of the conflict, setting the stage for a complex legal showdown.
The plaintiffs argued that the defendants had unlawfully used their patented manufacturing process for Phosphorous Pentachloride without authorization, seeking both an injunction to stop further infringement and damages to compensate for the harm caused. On the other side, the defendants were positioned to challenge the very legitimacy of the patent itself. The court framed several critical issues for determination: whether the defendants had indeed infringed the patented process, whether the plaintiffs were entitled to the remedies of injunction and damages, and crucially, whether Patent No. 172459 itself was valid or subject to revocation. This created a dual-front legal battle — one focused on the alleged act of infringement, and another aimed at dismantling the patent's foundation.
As of the proceedings on 24 February 2010, the matter remained pending before the court. The court had formally framed the key issues — infringement, entitlement to injunction and damages, and the validity or revocation of Patent No. 172459 — but the final determination on these questions had not yet been rendered. The outcome awaited further hearings and judicial deliberation.
For founders and IP professionals in the chemical and pharmaceutical sectors, this case underscores the importance of securing robust patent protection for manufacturing processes — not just the end products. Process patents can be powerful assets, but they are also vulnerable to challenges of validity and revocation. Businesses must ensure their patent documentation is airtight, maintain clear records of their proprietary processes, and be prepared to defend their patents on multiple fronts. Equally important, any company adopting a manufacturing process must conduct thorough due diligence to confirm that the process is not protected by an existing patent, thereby avoiding costly litigation and potential injunctions that could halt operations entirely.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Gujarat High Court. Understanding the court's reasoning in Rajnikant Devidas Shroff vs Pharma Chem is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
The North Face Apparel CorpvsController of Patents and Designs
The North Face Apparel Corp challenged the Controller of Patents' refusal of its patent application (No. 202147026139) titled 'Systems and Methods for End-to-End Article Management' before the Madras High Court under Section 117A of the Patents Act, 1970. The Controller had rejected the application citing lack of inventive step over prior art documents D21-D24. The Court held that the Controller erred by dissecting the claims into isolated elements rather than assessing the invention as a whole, and overlooked the use of spectrophotometer and invisible markers for tracking the manufacturing process, which were not disclosed in the cited prior art. The appeal was allowed and the Controller was directed to grant the patent.
Aventose Energy Private LimitedvsThe Assistant Controller of Patents & Designs, Patent Office Chennai
Aventose Energy Private Limited appealed under Section 117A of the Patents Act, 1970 against the refusal of its patent application (No. 202141019671) for a 'System and Method for Operating Automobiles with an Electric Drivetrain' featuring safe mode activation upon fault detection. The Madras High Court found that the Assistant Controller had contradicted the First Examination Report (which accepted novelty) by subsequently holding the invention lacked novelty without giving the applicant an opportunity to be heard. The court further held that the Controller improperly conflated novelty with inventive step under Section 2(1)(ja) and failed to properly analyze the claims against prior art documents D1–D4.
Apex Laboratories Pvt LtdvsElder Lifescience and Ambico Ayurvedic Health Care
Apex Laboratories Pvt Ltd, the prior adopter and registered proprietor of the trademark ZINCOVIT (TM No. 487453 in Class 5) since 1988, sought interim injunction against Elder Lifescience and Ambico Ayurvedic Health Care for using the deceptively similar mark NEO ZINCOVIT. The applicant also claimed copyright infringement of its registered artistic works (A-108878/2014) covering colour scheme, get-up, and layout. The Madras High Court was satisfied that the respondents were attempting to piggyback on the applicant's goodwill and granted interim injunctions on all three applications covering trademark infringement, copyright infringement, and passing off.
Radico Khaitan LimitedvsPicadilly Agro Industries Limited
This Special Leave Petition arose from a judgment dated 29-05-2026 in CS No. 8/2025 passed by the District Judge, Karnal, Haryana, concerning a trademark dispute over the marks 'Cashmere' and 'Kashmyr' used in relation to beer and vodka. The Supreme Court noted that a First Appeal (FAO-COM-11-2026) was already pending before the Division Bench of the Punjab and Haryana High Court, listed for 28.10.2026. The Court disposed of the SLP without adjudicating it on merits, requesting the High Court to pass an appropriate order regarding the ad interim injunction on the scheduled date.
Maharaja Agrasen Technical Educational Society (Regd.)vsMaharaja Agrasen Himalayan Garhwal University
The plaintiff, Maharaja Agrasen Technical Educational Society, filed a suit for permanent injunction against the defendant, Maharaja Agrasen Himalayan Garhwal University, alleging infringement and passing off regarding the use of the words 'Maharaja Agrasen' in the defendant's name. The Delhi High Court had previously granted a restraint order on 10.07.2026. During the pendency of the suit, the parties arrived at a settlement dated 14.09.2026, under which the defendant agreed to change its name through a statutory amendment while being permitted limited transitional use of its existing name. The court recorded the settlement, modified the interim order accordingly, and listed the matter for compliance reporting on 13.07.2027.
Varahi Diamonds And Finance LimitedvsSahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr.
This is a commercial suit filed by Varahi Diamonds And Finance Limited against Sahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr. before the Delhi High Court. The order is primarily procedural, dealing with the registration of the plaint, issuance of summons, directions for filing pleadings, and an interim injunction application. The matter was referred to mediation, with parties directed to appear before the Delhi High Court Mediation and Conciliation Centre.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.